Ford Stock Analysis: A Great Opportunity Ahead Of Earnings

Summary

  • Ford’s stock price has fallen roughly 12% since the beginning of March due to concerns over growth in China and the new F-150.ford stock analysis
  • The auto company has done a great job increasing market share in China even as the country goes through an economic downturn, setting itself up well for the second half.
  • Operations in Europe also appear capable of returning to profitability sooner than expected, with a break-even possibility this year providing huge upside potential.
  • I Know First algorithm is bullish about Ford, believing that the upcoming earnings report will act as a positive catalyst for the stock in a rebound from recent months.

Read The Full Analysis Here

SunPower Stock Analysis: Is It Time To Buy?

Summary

  • Chinese government has significantly increased China’s renewable energy goals.sunpower stock analysis
  • Establishing a valuable partnership with First Solar through a Yieldco can only benefit the stock price.
  • Increasing their business projects thanks to a lower cost funding.

Read The Full Article

Alcoa Stock Forecast: Exploiting The Market’s Alcove Could Be The Key To Survival For Alcoa (AA)

I Know First published on Seeking Alpha a bullish article about Alcoa, the company is engaged in lightweight metals engineering and manufacturing and operates in four segments: Alumina, Primary Metals, Global Rolled Products, and Engineered Products and Solutions. Having explained how I Know First’s algorithm works, it is worthwhile to see if the algorithm agrees with the bullish fundamental analysis of the company. The three-month and one-year forecasts for Alcoa Sciences are included.

Alcoa Stock Forecast

Ford Stock Forecast: An Algorithmic Forecast (F)

I Know First published a bullish article on Ford, an American automobile manufacturer, on Seeking Alpha. Having explained how I Know First’s algorithm works, it is worthwhile to see if the algorithm agrees with the bullish fundamental analysis of the company. The three-month and one-year forecasts for Ford are included. ford stock forecast

Amazon Stock Price Prediction: Even At All Time Highs, Bulls Are Still Right About Amazon(AMZN)

Amazon.com, Inc. turned 20 and celebrated the occasion with Prime Day, where customers can get special deals on many of the offerings from Amazon’s web site. Besides the birthday of the company, Prime Day could also be considered a celebration of the success of the company. The stock price has climbed roughly 50% year to date, and it has continued to climb to new all-time highs. With the company’s earnings report coming up a week from Thursday, now is a good time to reemphasize why this company remains a strong investment opportunity. Amazon stock forecast

Netflix Stock Forecast: Netflix Investors Should Consider Profit Taking At These Prices (NFLX)

I Know First published a bullish article on Netflix, a video streaming service in the US and internationally, on Seeking Alpha. Having explained how I Know First’s algorithm works and providing an example of its success in the past, it is worthwhile to see if the algorithm agrees with the bullish fundamental analysis of the company. The three-month and one-year forecasts for Netflix are included. netflix stock forecast

Gilead Stock Analysis: Buy Ahead Of The Upcoming Earnings (GILD)

Summary

  • Gilead Sciences has fallen over 6% since reaching an all time high on June 23rd.gilead stock analysis
  • The recent pullback is a great investing opportunity for long-term investors as concerns over HCV competition are overblown.
  • The valuation is very cheap, and the company is reducing its reliance on the HCV market.
  • I Know First Algorithm is bullish on Gilead Sciences in the long-term and believe it will reach new record highs.
Long-term investors should continue adding this stock at current prices. The recent pullback is a prime investing opportunity, as this stock is the most attractive option in not only the biotech sector, but quite possible of any stock on the market. The recent news that Harvoni was approved in Japan offers plenty of extra room for revenue growth, and the market in the US is far from drying out. Along with the new TFA drug trials for HIV patients and the potential for an acquisition to bolster its oncology offerings, there is plenty to be excited about moving forward.

Read The Full Article Here